The IRON-PATH II Echo-Substudy

Funding Information: The IRON-PATH II study was sponsored by CSL Vifor with coordination by Bellvitge Biomedical Research Institute (IDIBELL). The sponsor did not participate in the design of this study nor data analysis. An independent data and safety monitoring committee reviewed the data every 6 months. This study was approved by the local ethics committees for clinical research at each participating center and was conducted in accordance with the principles of the Declaration of Helsinki. All the patients gave written informed consent before entering this study. Funding Information: The authors kindly acknowledge all participants in the IRON-PATH II study. We thank CERCA Programme/Generalitat de Catalunya for their institutional support. We thank the Departament de Salut de la Generalitat de Catalunya through \u201CPla Estrat\u00E8gic de Recerca i Innovaci\u00F3 en Salut (PERIS 2023)\u201D grant number SLT028/23/000018 for financial support. Furthermore, we are grateful to the Centro de Investigaci\u00F3n Biom\u00E9dica en Red de Enfermedades Cardiovasculares (CIBERCV) for their institutional and financial support. Funding Information: This research received an unrestricted grant from CSL Vifor (Sponsor Reference IS-HUB-004/21 (IRON PATH II). Publisher Copyright: © 2025 by the authors.